Fjarde Ap-fonden’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.3M Buy
12,500
+700
+6% +$133K 0.03% 481
2023
Q4
$2.12M Buy
11,800
+300
+3% +$46.7K 0.03% 487
2023
Q3
$1.83M Buy
11,500
+6,500
+130% +$1.06M 0.02% 492
2023
Q2
$707K Sell
5,000
-1,400
-22% -$224K 0.01% 520
2023
Q1
$1.08M Buy
6,400
+1,800
+39% +$321K 0.01% 501
2022
Q4
$779K Buy
+4,600
New +$834K 0.01% 506

Other funds holding RGEN

Fjarde Ap-fonden's RGEN Position: Q1 2024 in Review

Fjarde Ap-fonden increased its Repligen (RGEN) stake by 5.9% in Q1 2024, buying an estimated $133K and bringing the position to 12,500 shares worth $2.3M. The position accounts for 0.03% of the portfolio, ranked #481.

Fjarde Ap-fonden first reported a position in RGEN in Q4 2022 and has held it in 6 quarters since. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.

  • Fjarde Ap-fonden held 12,500 shares of Repligen worth $2.3M as of Q1 2024.
  • Fjarde Ap-fonden bought 700 Repligen shares in Q1 2024, an estimated $133K.
  • Repligen made up 0.03% of Fjarde Ap-fonden's portfolio in Q1 2024, its #481 holding.
  • Fjarde Ap-fonden first reported a position in Repligen in Q4 2022 and has held it in 6 quarters since.
  • 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.

Based on Fjarde Ap-fonden's 13F filing for Q1 2024, filed 25 Apr 2024.